Ann-Kristin Schmälter^1*, Maud Ngoya^2*, Jürgen Finke, MD, PhD³, Nicolaus Kröger, MD^4*, Friedrich Stölzel^5*, Matthias Stelljes, MD⁶, Thomas Valerius^7*, Johanna Tischer, MD^8*, Thomas Schroeder, MD^9*, Peter Dreger, MD¹⁰, Igor Wolfgang Blau, MD^11*, Bipin Savani, MD¹², Sebastian Giebel, MD, PhD^13*, Jordi Esteve, MD, PhD¹⁴, Ali Bazarbachi, MD, PhD¹⁵, Arnon Nagler, MD¹⁶, Christoph Schmid, MD^17*, Fabio Ciceri, MD^18* and Mohamad Mohty, MD PhD¹⁹

¹Section for Stem Cell Transplantation, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
²Department of Hematology and Cell Therapy, EBMT Paris Study Office, Paris, France
³Department of Medicine, Hematology-Oncology, University of Freiburg, Freiburg, Germany
⁴University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
⁵Department of Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany
⁶Department of Hematology, Oncology and Pneumology, University of Münster, Münster, Germany
⁷Division of Stem Cell Transplantation and Immunotherapy, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
⁸Department of Internal Medicine III, University Hospital of Munich, Campus Grosshadern, Munich, -, Germany
⁹Department of Bone Marrow Transplantation, University Hospital Duesseldorf, Essen, Germany
¹⁰Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
¹¹Department of BMT, Clinic of Hematology, Oncology and Tumorimmunology, University Medicine Berlin, Berlin, Germany
¹²Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
¹³Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice, Poland
¹⁴Hematology department, Hospital Clínic Barcelona, Barcelona, Spain
¹⁵American University of Beirut Dept. of Medicine, Beirut, Lebanon
¹⁶Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
¹⁷Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
¹⁸Hematology and BMT Unit, IRCCS Ospedale San Raffaele, University Vita-Salute San Raffaele, Milano, Milan, Italy
¹⁹Department of Hematology and Cell Therapy, EBMT Paris study office, Saint Antoine Hospital, Paris, France

Xing-yu Cao, MD^1*, Jian-Ping Zhang, MD^2*, Yan-Li Zhao^1*, Min Xiong^2*, Jiarui Zhou^3*, Yue Lu^4*, Ruijuan Sun^2*, Zhijie Wei^4*, Deyan Liu^5*, Xian Zhang³, Junfang Yang^3* and Peihua Lu, MD^3*

¹Hebei Yanda Lu Daopei Hospital, Langfang, CHN
²Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
³Hebei Yanda Lu Daopei Hospital, Langfang, China
⁴Bone Marrow Transplant Department, Hebei Yanda Lu Daopei Hospital, Langfang, China
⁵Hebei Yanda Ludaopei Hospital, Langfang, China

Katie Maurer, MD, PhD^1,2, Haesook T Kim, PhD³, Heather Garrity, MHA^4*, Carol Reynolds, PhD^5*, Deborah Liney^6*, Augustine Weber^7*, Joseph H. Antin, MD⁸, Corey Cutler, MD, MPH, FRCPC⁹, Jerome Ritz, MD, PhD⁹, John Koreth, MBBS, DPhil⁹, Roman M Shapiro, MD², Rizwan Romee, MD¹⁰, Vincent Ho, MD^7*, Mahasweta Gooptu, MD¹¹, Catherine J. Wu, MD¹², Sarah Nikiforow, MD, PhD^11,13 and Robert J Soiffer, MD⁹

¹Harvard Medical School, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Harvard School of Public Health, Boston, MA
⁴Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Dana-Farber Cancer Institute, Boston
⁸Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Dana-Farber Cancer Institute, Division of Hematologic Malignancies and Harvard Medical School, Boston, MA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Dana-Farber Cancer Institute and Harvard Medical School, Boston
¹³Connell & O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston

Katie Maurer, MD, PhD^1,2, Cameron Y Park^3*, Mehdi Borji^4*, Shouvik Mani^5*, Jackson Southard, BS^6*, Samouil L Farhi, PhD^7*, Domenic Abbondanza^7*, Shuqiang Li, PhD^1,6*, Kenneth J Livak, PhD^6,8*, Jerome Ritz, MD, PhD^9,10, Robert J Soiffer, MD^9,10, Pavan Bachireddy, MD¹¹, Catherine J. Wu, MD^1,2,8 and Elham Azizi, PhD^3*

¹Broad Institute of MIT and Harvard, Cambridge, MA
²Harvard Medical School, Boston, MA
³Department of Biomedical Engineering and Irving Institute for Cancer Dynamics, Columbia University, New York, NY
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Computer Science and Irving Institute for Cancer Dynamics, Columbia University, New York, NY
⁶Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
⁷Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Medicine, Brigham and Women's Hospital, Boston, MA
¹⁰Dana-Farber Cancer Institute, Division of Hematologic Malignancies and Harvard Medical School, Boston, MA
¹¹Department of Hematopoietic Biology & Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX

Dominic Brauer, MD^1*, Lara Bischof^1*, Jule Ussmann, MD^1*, Donata Backhaus, MD^1*, Georg-Nikolaus Franke, MD^1*, Vladan Vucinic, MD^1*, Marco Herling, MD^1*, Maximilian Merz, MD¹, Leanthe Braunert, MD^2*, Doreen Hammerschmidt, MD^3*, Alexander Kühnemund, MD^4*, Anne Weigert^1*, Klaus H. Metzeler, MD¹, Uwe Platzbecker, MD^1*, Madlen Jentzsch, MD^1* and Sebastian Schwind, MD^1*

¹Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
²Department for Hematolgy and Oncology, Medical Care Center Nordsachsen, Schkeuditz, Germany
³Department for Hematology and Oncology, Medical Care Center, Helios Clinic Plauen, Plauen, Germany
⁴Department for Hematology and Oncology, Medical Care Center, Alexianer St. Hedwig Clinic, Berlin, Germany

Kyoko Fuse, MD, PhD^1*, Tatsuya Suwabe, MD, Ph.D^2*, Takayuki Katagiri, MD^2*, Yasuhiko Shibasaki, MD^2*, Hirohito Sone, MD, Ph.D^2* and Masayoshi Masuko, MD³

¹Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan
²Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
³Niigata University Medical and Dental Hospital, Department of Hematopoietic Cell Therapy,, Niigata, Japan

Jonathan Allen Webster, MD¹, Madison C Reed, BS², Hua-Ling Tsai^3*, Alexander J. Ambinder, MD, MPH⁴, Tania Jain, MD⁵, Amy E. DeZern, MD⁴, Mark J. Levis, MD⁶, Margaret M. Showel, MD^7*, Gabrielle T. Prince, MD^5*, Christopher S. Hourigan, MD PhD⁵, Javier Bolaños-Meade, MD³, Lukasz P. Gondek, MD, PhD⁸, Gabriel Ghiaur, MD, PhD⁹, William Brian Dalton, MD, PhD¹⁰, Suman Paul, PhD, MD¹¹, Ephraim J. Fuchs, MD, MBA³, Christian B. Gocke, MD, PhD¹², Abbas Abbas Ali, MD¹³, Douglas E Gladstone, MD³, Carol Ann Huff, MD³, Ivan M. Borrello, MD³, Lode J. Swinnen, MB ChB¹⁴, Nina D. Wagner-Johnston, MD⁹, Richard F. Ambinder, MD, PhD¹⁵, Leo Luznik, MD^3*, Ivana Gojo, MD³, B. Douglas Douglas Smith, MD¹⁶, Ravi Varadhan, PhD^3*, Richard J. Jones, MD³ and Philip H. Imus, MD³

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
²Johns Hopkins University, Baltimore, MD
³Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁴Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁵The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
⁶Director, Adult Leukemia Program, Co-Division Director, Hematologic Malignancies, Professor of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD
⁷Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁸Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
⁹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
¹⁰Johns Hopkins Hospital, Baltimore, MD
¹¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Toledo, OH
¹²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins/Sidney Kimmel Cancer Center, Baltimore, MD
¹³Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
¹⁴Division of Medical Oncology, Johns Hopkins Cancer Center, Baltimore, MD
¹⁵Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD
¹⁶Sidney Kimmel Comprehensive Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Weihao Chen^1*, Luo Huang^1*, Zhuoyue Shi^1*, Jimin Shi, M.D.^2,3,4*, Yi Luo, M.D.^2,3,4*, Jian Yu, Ph.D.^2,3,4*, Xiaoyu Lai, M.D.^2,3,4*, Lizhen Liu, M.D.^2,3,4*, Huarui Fu^1,3,4*, Zhongzheng Zheng^5*, He Huang, Ph.D., M.D.^1,3,4,6 and Yanmin Zhao^1,3,4*

¹Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China
³Institute of Hematology, Zhejiang University, Hangzhou, China
⁴Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁵Shanghai Dishuo Beken Biotechnology Co., Ltd., Shanghai, China
⁶Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China

Jule Ussmann, MD^*, Lara Bischof^*, Dominic Brauer, MD^*, Donata Backhaus, MD^*, Marco Herling, MD^*, Klaus H. Metzeler, MD, Maximilian Merz, MD, Vladan Vucinic, MD^*, Georg-Nikolaus Franke, MD^*, Uwe Platzbecker, MD, Sebastian Schwind, MD^* and Madlen Jentzsch, MD^*

Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

Tamer Othman, MD^1,2*, Paul B. Koller, MD³, Ni-Chun Tsai, MS^4*, Hoda Pourhassan, MD^3*, Vaibhav Agrawal, MD², Salman Otoukesh, MD^3*, Idoroenyi Amanam, MD³, Dat Ngo, PharmD^5*, Jason Chen, PharmD^5*, Monzr M. Al Malki, MD³, Amandeep Salhotra, MD³, Haris Ali, MD³, Ahmed Aribi, MD³, Karamjeet S. Sandhu, MD³, Shukaib Arslan, MD^3*, Brian J Ball, MD³, Forrest M. Stewart, MD^3*, Peter T. Curtin, MD³, Andrew S. Artz, MD, MS³, David S Snyder, MD², Guido Marcucci, MD³, Stephen J Forman, MD³, Anthony S. Stein, MD³, Ryotaro Nakamura, MD², Vinod A. Pullarkat, MD^3*, Ibrahim Aldoss, MD³ and Matthew Mei, MD⁶

¹University of California Davis Comprehensive Cancer Center, Sacramento, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁴Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
⁵Department of Pharmacy, City of Hope National Medical Center, Duarte, CA
⁶Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA

Krithika Chennapan^1*, Karam Ashouri, MD^1*, Anastasia Martynova, MD², Samvel Nazaretyan^1*, Amir Ali, PharmD^3*, Eric Tam, MD², Abdullah Ladha, MD, MPH², Karrune Woan, MD, PhD², Preet M. Chaudhary, MD, PhD², Imran Siddiqi, MD PhD^4* and George Yaghmour, MD²

¹University of Southern California, Los Angeles
²Division of Hematology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
³University of Southern California Norris Comprehensive Cancer Center, Los Angeles
⁴Dept. of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA

Shona Philip, MD¹, Robert Lowsky, MD¹, Laura J. Johnston, MD¹, Sally Arai, MD², Everett H Meyer, MD, PhD^1*, Robert S. Negrin, MD¹, Andrew R. Rezvani, MD³, Parveen Shiraz, MD¹, Judith A Shizuru, MD, PhD⁴, Surbhi Sidana, MD⁵, Wen-Kai Weng, MD, PhD⁶, Sushma Bharadwaj, MD, MS^4*, Matthew J Frank, MD, PhD⁷, David B. Miklos, MD, PhD¹, Melody Smith, MD, MS⁸, Lori Muffly, MD⁴ and Vaibhav Agrawal, MD⁹

¹Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA
³Stanford University School of Medicine, Stanford
⁴Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁵Division of BMT and Cell Therapy, Stanford University Hospital, Stanford, CA
⁶Stanford Univ. School of Med., Stanford, CA
⁷Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁸Adult Bone Marrow Transplant Service and Cellular Therapeutics Center, Stanford University, Stanford, CA
⁹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Cuiyan Zhou^1*, Fengmei Zheng^2*, Lanping Xu, MD, PhD^3*, Xiaohui Zhang^4*, Yingjun Chang^3*, Xiao-Dong Mo^5*, Yuqian Sun, MD^6*, Xiao-Jun Huang⁷ and Yu Wang^7*

¹Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
²Peking University People’s Hospital, Beijing, China
³Peking University Institute of Hematology, Beijing, China
⁴Peking University people hospital, Beijing, China
⁵Peking University People’s Hospital, Beijing, Beijing, China
⁶Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁷Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China

Silvia Park^1*, Daehun Kwag^2*, Su Yeon Bang, MD^3*, Jong-Hyuk Lee, M.D.^4*, Gi June Min, M.D., Ph.D.^4*, Sung-Soo Park, M.D., Ph.D.^5*, Seung-Ah Yahng, M.D., Ph.D.^6*, Young-Woo Jeon, M.D., Ph.D.^7*, Seung-Hwan Shin, M.D., Ph.D.^8*, Jae-Ho Yoon, M.D., Ph.D.⁴, Sung-Eun Lee, MD^4*, Byung-Sik Cho, M.D., Ph.D.^4*, Ki-Seong Eom, M.D., Ph.D.^4*, Seok Lee, M.D., Ph.D.⁴, Hee-Je Kim, M.D., Ph.D.⁴, Chang-Ki Min, MD, PhD^4*, Seok-Goo Cho, M.D., Ph.D.^4*, Jong Wook Lee, M.D., Ph.D.⁴ and Yoo-Jin Kim, M.D., Ph.D.⁴

¹Department of Hematology, Catholic Hematology Hospital,Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, Korea, Republic of (South)
²Department of Hematology, Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
⁴Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, KOR
⁶Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of (South)
⁷Department of Hematology, Yeouido St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁸Dep. of Hematology, Hematology Institute, Eunpyeung St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)